Archives: FAQs
-
How does a civil action under 35 U.S.C. 145 differ from a direct appeal to the Federal Circuit?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
How does the 35 U.S.C. 121 prohibition affect statutory double patenting rejections?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
Does the 35 U.S.C. 121 safe harbor protection apply to all types of continuing applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
How does 35 U.S.C. 121 relate to restriction requirements in patent applications?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information…
-
What does 35 U.S.C. 121 say about patent validity and restriction requirements?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules4 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
What protection does 35 U.S.C. 121 provide to patent holders regarding improper joinder?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 9 Rules4 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
What is the purpose of 35 U.S.C. 121 in relation to double patenting?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information…
-
What is the significance of the 30-month time limit for national stage entry?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
What are the implications of the 2007 USPTO policy change for pending applications with multiple nucleotide sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…
-
What is the difference between the 1996 and 2007 USPTO policies on nucleotide sequences?
Source: FAQ (MPEP-Based)BlueIron Update: 2024-09-27 10 Rules5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth…